Icecure Medical (NASDAQ: ICCM) reported Q2 2024 earnings per share (EPS) of -$0.06, up 33.33% year over year. Total Icecure Medical earnings for the quarter were -$3.08 million. In the same quarter last year, Icecure Medical's earnings per share (EPS) was -$0.09.
As of Q3 2024, Icecure Medical's earnings has grown year over year. Icecure Medical's earnings in the past year totalled -$13.69 million.
What was ICCM's revenue last quarter?
Icecure Medical (NASDAQ: ICCM) reported Q2 2024 revenue of $1.01 million up 7.9% year over year. In the same quarter last year, Icecure Medical's revenue was $937.00 thousand.
What was ICCM's revenue growth in the past year?
As of Q3 2024, Icecure Medical's revenue has grown 3.6% year over year. This is 6.86 percentage points lower than the US Medical Devices industry revenue growth rate of 10.46%. Icecure Medical's revenue in the past year totalled $3.34 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.